Price
$174.96
Decreased by -0.87%
Dollar volume (20D)
74.64 M
ADR%
3.54
Earnings report date
Sep 9, 2025
Shares float
59.90 M
Shares short
2.26 M [3.78%]
Shares outstanding
60.49 M
Market cap
10.72 B
Beta
0.36
Price/earnings
N/A
20D range
166.84 180.78
50D range
150.89 183.00
200D range
118.03 183.00

Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.

The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism.

It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates.

The company was incorporated in 2006 and is based in Hellerup, Denmark.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
Apr 30, 25 -1.58
Increased by +31.30%
-1.51
Decreased by -4.95%
Feb 12, 25 -0.64
Increased by +58.44%
-0.98
Increased by +34.69%
Nov 5, 24 -1.72
Increased by +40.28%
-1.89
Increased by +8.99%
Sep 3, 24 -2.11
Increased by +2.31%
-1.46
Decreased by -44.52%
May 2, 24 -2.30
Decreased by -16.16%
-1.50
Decreased by -53.33%
Feb 7, 24 -1.54
Increased by +58.38%
-2.03
Increased by +24.14%
Nov 7, 23 -2.88
Increased by +4.95%
-2.38
Decreased by -21.01%
Sep 5, 23 -2.16
Decreased by -47.95%
-2.59
Increased by +16.60%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Mar 31, 25 100.95 M
Increased by +5.28%
-94.63 M
Increased by +27.79%
Decreased by -93.73%
Increased by +31.41%
Dec 31, 24 173.92 M
Increased by +26.30%
-38.47 M
Increased by +55.72%
Decreased by -22.12%
Increased by +64.94%
Sep 30, 24 57.83 M
Increased by +20.40%
-99.20 M
Increased by +38.85%
Decreased by -171.52%
Increased by +49.21%
Jun 30, 24 36.00 M
Decreased by -24.04%
-109.38 M
Increased by +9.93%
Decreased by -303.85%
Decreased by -18.59%
Mar 31, 24 95.89 M
Increased by +185.49%
-131.03 M
Decreased by -18.14%
Decreased by -136.65%
Increased by +58.62%
Dec 31, 23 137.70 M
Increased by +501.42%
-86.88 M
Increased by +58.11%
Decreased by -63.09%
Increased by +93.04%
Sep 30, 23 48.03 M
Increased by +214.15%
-162.22 M
Increased by +3.98%
Decreased by -337.73%
Increased by +69.44%
Jun 30, 23 47.39 M
Increased by +669.37%
-121.43 M
Decreased by -49.33%
Decreased by -256.23%
Increased by +80.59%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY